Estramustine phosphate in prostate cancer. EORTC experience: preliminary results of Protocol 30762.
D001530:Belgium; D002986:Clinical Trials as Topic; D004054:Diethylstilbestrol / Q000627:therapeutic use; D004961:Estramustine / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D006801:Humans; D008297:Male; D009367:Neoplasm Staging; D009588:Nitrogen Mustard Compounds / Q000627:therapeutic use*; D011379:Prognosis; D011471:Prostatic Neoplasms / Q000188:drug therapy* / Q000401:mortality / Q000473:pathology; D011897:Random Allocation; D013997:Time Factors; D006113:United Kingdom
D009588:Nitrogen Mustard Compounds; D004961:Estramustine; D004054:Diethylstilbestrol